Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306320003> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4306320003 abstract "Abstract Background Among patients with atrial fibrillation (AF) and stable coronary artery disease, bleeding events increased the cardiovascular events and mortality. We aimed to evaluate the effect of proton pump inhibitor (PPI) on the risk of bleeding events in these patients. Methods In the AFIRE (Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease), patients with non-valvular AF and coronary artery disease were recruited and randomized to receive the rivaroxaban monotherapy or combination therapy with rivaroxaban plus antiplatelet drug. The present sub-analysis evaluated the risks of any bleeding events. Results Among 2,225 patients, 1,357 (61.3%) were receiving a PPI at baseline. During follow-up, 384 bleeding events were occurred, and incidence of bleeding events were significantly lower in patients with PPI compared with those without PPI (p=0.03). Among combination therapy with rivaroxaban plus antiplatelet, effect of PPI for cumulative incidence of bleeding events were significantly different between groups (p=0.01), however, these differences were not shown among rivaroxaban monotherapy patients (p=0.50, Figure 1). Multivariate Cox hazard analysis showed that PPI use had significantly lower risk of bleeding events (hazard risk 0.79, 95% confidence interval 0.64–0.97, p=0.03). In addition to PPI, male, heart failure and combination therapy with rivaroxaban plus antiplatelet drug were independent predictors of bleeding events. Conclusions PPI use was significantly associated with lower risk of bleeding events among patients with AF and stable coronary artery disease. Especially, for patients at high bleeding risk, such as receiving both anticoagulant and antiplatelet drugs, PPI is useful to reduce bleeding events. Funding Acknowledgement Type of funding sources: Private company. Main funding source(s): The Japan Cardiovascular Foundation through a contract with Bayer Yakuhin." @default.
- W4306320003 created "2022-10-16" @default.
- W4306320003 creator A5000176175 @default.
- W4306320003 creator A5002163444 @default.
- W4306320003 creator A5013190350 @default.
- W4306320003 creator A5015932449 @default.
- W4306320003 creator A5022030714 @default.
- W4306320003 creator A5023792530 @default.
- W4306320003 creator A5034004259 @default.
- W4306320003 creator A5037592709 @default.
- W4306320003 creator A5052154025 @default.
- W4306320003 creator A5054336931 @default.
- W4306320003 creator A5079485654 @default.
- W4306320003 creator A5084234999 @default.
- W4306320003 creator A5065608986 @default.
- W4306320003 date "2022-10-01" @default.
- W4306320003 modified "2023-09-26" @default.
- W4306320003 title "Antithrombotic and proton pump inhibitor co-therapy in patients with atrial fibrillation and stable coronary disease: a post hoc analysis of the AFIRE trial" @default.
- W4306320003 doi "https://doi.org/10.1093/eurheartj/ehac544.1377" @default.
- W4306320003 hasPublicationYear "2022" @default.
- W4306320003 type Work @default.
- W4306320003 citedByCount "0" @default.
- W4306320003 crossrefType "journal-article" @default.
- W4306320003 hasAuthorship W4306320003A5000176175 @default.
- W4306320003 hasAuthorship W4306320003A5002163444 @default.
- W4306320003 hasAuthorship W4306320003A5013190350 @default.
- W4306320003 hasAuthorship W4306320003A5015932449 @default.
- W4306320003 hasAuthorship W4306320003A5022030714 @default.
- W4306320003 hasAuthorship W4306320003A5023792530 @default.
- W4306320003 hasAuthorship W4306320003A5034004259 @default.
- W4306320003 hasAuthorship W4306320003A5037592709 @default.
- W4306320003 hasAuthorship W4306320003A5052154025 @default.
- W4306320003 hasAuthorship W4306320003A5054336931 @default.
- W4306320003 hasAuthorship W4306320003A5065608986 @default.
- W4306320003 hasAuthorship W4306320003A5079485654 @default.
- W4306320003 hasAuthorship W4306320003A5084234999 @default.
- W4306320003 hasBestOaLocation W43063200031 @default.
- W4306320003 hasConcept C120665830 @default.
- W4306320003 hasConcept C121332964 @default.
- W4306320003 hasConcept C126322002 @default.
- W4306320003 hasConcept C164705383 @default.
- W4306320003 hasConcept C207103383 @default.
- W4306320003 hasConcept C2776301958 @default.
- W4306320003 hasConcept C2777015399 @default.
- W4306320003 hasConcept C2777265216 @default.
- W4306320003 hasConcept C2777849778 @default.
- W4306320003 hasConcept C2778213512 @default.
- W4306320003 hasConcept C2778661090 @default.
- W4306320003 hasConcept C2779161974 @default.
- W4306320003 hasConcept C44249647 @default.
- W4306320003 hasConcept C500558357 @default.
- W4306320003 hasConcept C61511704 @default.
- W4306320003 hasConcept C71924100 @default.
- W4306320003 hasConceptScore W4306320003C120665830 @default.
- W4306320003 hasConceptScore W4306320003C121332964 @default.
- W4306320003 hasConceptScore W4306320003C126322002 @default.
- W4306320003 hasConceptScore W4306320003C164705383 @default.
- W4306320003 hasConceptScore W4306320003C207103383 @default.
- W4306320003 hasConceptScore W4306320003C2776301958 @default.
- W4306320003 hasConceptScore W4306320003C2777015399 @default.
- W4306320003 hasConceptScore W4306320003C2777265216 @default.
- W4306320003 hasConceptScore W4306320003C2777849778 @default.
- W4306320003 hasConceptScore W4306320003C2778213512 @default.
- W4306320003 hasConceptScore W4306320003C2778661090 @default.
- W4306320003 hasConceptScore W4306320003C2779161974 @default.
- W4306320003 hasConceptScore W4306320003C44249647 @default.
- W4306320003 hasConceptScore W4306320003C500558357 @default.
- W4306320003 hasConceptScore W4306320003C61511704 @default.
- W4306320003 hasConceptScore W4306320003C71924100 @default.
- W4306320003 hasIssue "Supplement_2" @default.
- W4306320003 hasLocation W43063200031 @default.
- W4306320003 hasOpenAccess W4306320003 @default.
- W4306320003 hasPrimaryLocation W43063200031 @default.
- W4306320003 hasRelatedWork W1982427773 @default.
- W4306320003 hasRelatedWork W2513168644 @default.
- W4306320003 hasRelatedWork W2606162097 @default.
- W4306320003 hasRelatedWork W2635405885 @default.
- W4306320003 hasRelatedWork W2789232128 @default.
- W4306320003 hasRelatedWork W2794057425 @default.
- W4306320003 hasRelatedWork W2805259111 @default.
- W4306320003 hasRelatedWork W3130040365 @default.
- W4306320003 hasRelatedWork W3141700921 @default.
- W4306320003 hasRelatedWork W4248905858 @default.
- W4306320003 hasVolume "43" @default.
- W4306320003 isParatext "false" @default.
- W4306320003 isRetracted "false" @default.
- W4306320003 workType "article" @default.